Gene therapy for colon cancer

Hematology/Oncology Clinics of North America

Volumn 12, Issue 3, 1998, Pages 595-615

  Zwacka, R M ^a   Dunlop, M G ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; INTERLEUKIN 2; VIRUS VECTOR;

CANCER COMBINATION CHEMOTHERAPY; CANCER INHIBITION; COLORECTAL CANCER; GENE TARGETING; GENE THERAPY; HUMAN; IMMUNOMODULATION; METASTASIS INHIBITION; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; REVIEW; SUICIDE GENE; TUMOR SUPPRESSOR GENE;

EID: 0031823551     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(05)70010-1     Document Type: Article

References (56)

1. S.N. Agoff J. Hou D.I. Linzer B. Wu Regulation of the human hsp70 promoter by p53 Science 259 1993 84
2. T. Aoki K. Tashiro S. Miyatake Expression of murine interleukin 7 in a murine glioma cell line results in reduced tumorigenicity in vivo Proc Natl Acad Sci USA 89 1992 3850
3. D. Berd H.C.J. Maguire P. McCue M.J. Mastrangelo Treatment of metastatic melanoma with an autologous tumor-cell vaccine: Clinical and immunologic results in 64 patients J Clin Oncol 8 1990 1858
4. J.R. Bischoff D.H. Kim A. Williams An adenovirus mutant that replicates selectively in p53-deficient human tumor cells [see comments] Science 274 1996 373
5. E.C. Borden P.M. Sondel Lymphokines and cytokines as cancer treatment. Immunotherapy realized Cancer 65 1990 800
6. J.C. Bystryn R. Oratz D. Roses Relationship between immune response to melanoma vaccine immunization and clinical outcome in stage II malignant melanoma Cancer 69 1992 1157
7. M. Caruso K. Pham-Nguyen Y.L. Kwong Adenovirus-mediated interleukin-12 gene therapy for metastatic colon carcinoma Proc Natl Acad Sci USA 93 1996 11302
8. S.H. Chen X.H. Chen Y. Wang Combination gene therapy for liver metastasis of colon carcinoma in vivo Proc Natl Acad Sci USA 92 1995 2577
9. A.M. Cohen N.E. Kemeny C.H. Kohne Is intra-arterial chemotherapy worthwhile in the treatment of patients with unresectable hepatic colorectal cancer metastases? Eur J Cancer 32A 1996 2195
10. M.P. Colombo L. Lombardi C. Melani Hypoxic tumor cell death and modulation of endothelial adhesion molecules in the regression of granulocyte colony-stimulating factor–transduced tumors Am J Pathol 148 1996 473
11. R.M. Conry A.F. LoBuglio J. Kantor Immune response to a carcinoembryonic antigen polynucleotide vaccine Cancer Res 54 1994 1164
12. R.M. Conry A.F. LoBuglio F. Loechel A carcinoembryonic antigen polynucleotide vaccine has in vivo antitumor activity Gene Ther 2 1995 59
13. R.G. Crystal E. Hirschowitz M. Lieberman Phase I study of direct administration of a replication deficient adenovirus vector containing the E. coli cytosine deaminase gene to metastatic colon carcinoma of the liver in association with the oral administration of the pro-drug 5-fluorocytosine Hum Gene Ther 8 1997 985
14. el-Deiry W.S. T. Tokino V.E. Velculescu WAF1, a potential mediator of p53 tumor suppression Cell 75 1993 817
15. L.A. Donehower M. Harvey B.L. Slagle Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours Nature 356 1992 215
16. E.R. Fearon D.M. Pardoll T. Itaya Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response Cell 60 1990 397
17. T. Felzmann W.J. Ramsey R.M. Blaese Characterization of the antitumor immune response generated by treatment of murine tumors with recombinant adenoviruses expressing HSVtk, IL-2, IL-6 or B7-1 [In Process Citation] Gene Ther 4 1997 1322
18. Y. Fong N. Kemeny P. Paty Treatment of colorectal cancer: Hepatic metastasis Semin Surg Oncol 12 1996 219
19. S.M. Freeman R. Ramesh M. Shastri The role of cytokines in mediating the bystander effect using HSV-TK xenogeneic cells Cancer Lett 92 1995 167
20. C. Fuchs F. Krapf P. Kern CEA-containing immune complexes in sera of patients with colorectal and breast cancer—analysis of complexed immunoglobulin classes Cancer Immunol Immunother 26 1988 180
21. T.G. Graeber J.F. Peterson M. Tsai Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status Mol Cell Biol 14 1994 6264
22. N.N. Hanna H.J. Mauceri J.D. Wayne Virally directed cytosine deaminase/5-fluorocytosine gene therapy enhances radiation response in human cancer xenografts Cancer Res 57 1997 4205
23. D. Hochhauser Modulation of chemosensitivity through altered expression of cell cycle regulatory genes in cancer Anticancer Drugs 8 1997 903
24. M. Hollstein K. Rice M.S. Greenblatt Database of p53 gene somatic mutations in human tumors and cell lines Nucl Acids Res 22 1994 3551
25. B.E. Huber E.A. Austin S.S. Good In vivo antitumor activity of 5-fluorocytosine on human colorectal carcinoma cells genetically modified to express cytosine deaminase Cancer Res 53 1993 4619
26. B.E. Huber E.A. Austin C.A. Richards Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: Significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase Proc Natl Acad Sci USA 91 1994 8302
27. D.L. Jicha J.J. Mule S.A. Rosenberg Interleukin 7 generates antitumor cytotoxic T lymphocytes against murine sarcomas with efficacy in cellular adoptive immunotherapy J Exp Med 174 1991 1511
28. J. Kantor K. Irvine S. Abrams Antitumor activity and immune responses induced by a recombinant carcinoembryonic antigen-vaccinia virus vaccine J Natl Cancer Inst 84 1992 1084
29. H. Kaufman J. Schlom J. Kantor A recombinant vaccinia virus expressing human carcinoembryonic antigen (CEA) Int J Cancer 48 1991 900
30. A. Kelso Cytokines: Structure, function and synthesis Curr Opin Immunol 2 1989 215
31. A. Kieser H.A. Weich G. Brandner Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression Oncogene 9 1994 963
32. L.J. Ko C. Prives p53: Puzzle and paradigm Genes Dev 10 1996 1054
33. D.P. Lane L.V. Crawford T antigen is bound to a host protein in SV40-transformed cells Nature 278 1979 261
34. W. Li K. Berencsi S. Basak Human colorectal cancer (CRC) antigen CO17-1A/GA733 encoded by adenovirus inhibits growth of established CRC cells in mice J Immunol 159 1997 763
35. D.I. Linzer A.J. Levine Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells Cell 17 1979 43
36. M.T. Lotze S.A. Rosenberg Results of clinical trials with the administration of interleukin 2 and adoptive immunotherapy with activated cells in patients with cancer Immunobiology 172 1986 420
37. S.W. Lowe S. Bodis A. McClatchey p53 status and the efficacy of cancer therapy in vivo Science 266 1994 807
38. A. Martinotti A. Stoppacciaro M. Vagliani CD4 T cells inhibit in vivo the CD8-mediated immune response against murine colon carcinoma cells transduced with interleukin-12 genes Eur J Immunol 25 1995 137
39. M.S. Mitchell W. Harel R.A. Kempf Active-specific immunotherapy for melanoma J Clin Oncol 8 1990 856
40. F.L. Moolten Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: Paradigm for a prospective cancer control strategy Cancer Res 46 1986 5276
41. L.L. Nielsen D.C. Maneval P53 tumor suppressor gene therapy for cancer Cancer Gene Ther 5 1998 52
42. K.P. O'Boyle R. Zamore S. Adluri Immunization of colorectal cancer patients with modified ovine submaxillary gland mucin and adjuvants induces IgM and IgG antibodies to sialylated Tn Cancer Res 52 1992 5663
43. M. Oren Relationship of p53 to the control of apoptotic cell death Semin Cancer Biol 5 1994 221
44. G. Riethmuller E. Schneider-Gadicke G. Schlimok Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group Lancet 343 1994 1177
45. S.A. Rosenberg The development of new immunotherapies for the treatment of cancer using interleukin-2. A review Ann Surg 208 1988 121
46. P.J. Ross D. Cunningham Chemotherapy of metastatic bowel cancer Br J Hosp Med 55 1996 263
47. Y. Sato Y. Koshita M. Hirayama Augmented antitumor effects of killer cells induced by tumor necrosis factor gene-transduced autologous tumor cells from gastrointestinal cancer patients Hum Gene Ther 7 1996 1895
48. J. Scheele R. Stang A. Altendorf-Hofmann M. Paul Resection of colorectal liver metastases World J Surg 19 1995 59
49. J.E. Shively J.D. Beatty CEA-related antigens: Molecular biology and clinical significance Crit Rev Oncol Hematol 2 1985 355
50. R.E. Sobol I. Royston H. Fakhrai Injection of colon carcinoma patients with autologous irradiated tumor cells and fibroblasts genetically modified to secrete interleukin-2 (IL-2): a phase I study Hum Gene Ther 6 1995 195
51. R.I. Tepper R.L. Coffman P. Leder An eosinophil-dependent mechanism for the antitumor effect of interleukin-4 Science 257 1992 548
52. J.A. Thompson F. Grunert W. Zimmermann Carcinoembryonic antigen gene family: Molecular biology and clinical perspectives J Clin Lab Anal 5 1991 344
53. A.D. Van S.J. Martin T. Kafri Suppression of TNF-alpha–induced apoptosis by NF-kappaB Science 274 1996 787
54. C.A. Westbrook S.J. Chmura R.B. Arenas Human APC gene expression in rodent colonic epithelium in vivo using liposomal gene delivery Hum Mol Genet 3 1994 2005
55. L. Zitvogel H. Tahara P.D. Robbins Cancer immunotherapy of established tumors with IL-12: Effective delivery by genetically engineered fibroblasts J Immunol 155 1995 1393
56. G. Zund D.P. Nelson E.J. Neufeld Hypoxia enhances stimulus-dependent induction of E-selection on aortic endothelial cells Proc Natl Acad Sci USA 93 1996 7075